Back to search

Article

Neuroprotective effects of Canagliflozin: lessons from aged genetically diverse UM-HET3 mice

2022-01-28

Abstract excerpt

The aging brain is characterized by a progressive increase in neuroinflammation and central insulin resistance, which contribute to neurodegenerative diseases and cognitive impairment. Recently, the Interventions Testing Program (ITP) demonstrated that the anti-diabetes drug, Canagliflozin (Cana), a sodium-glucose transporter 2 inhibitor (SGLT2i), led to lower fasting glucose and improved glucose tolerance in both...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f6e1a73-8822-550d-92b2-db2787d9be5b
DOI
10.1101/2022.01.27.478017
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neuroprotective effects of Canagliflozin: lessons from aged genetically diverse UM-HET3 miceDOI 10.1101/2022.01.27.478017
Select a neighboring publication to make it the new centre.